Executive Leadership |
 |
|
Marc Owen is President of McKesson Specialty Health, a division of McKesson Corporation. He joined McKesson in 2001, and previously served as executive vice president of corporate strategy and business development for McKesson Corporation, where he was responsible for overall corporate strategy, mergers and acquisitions, and business development. In addition, he was responsible for McKesson’s operations in Mexico and Asia Pacific Prior to joining McKesson, Owen was a senior partner at McKinsey, advising pharmaceutical manufacturers, healthcare providers, distributors and technology companies, including McKesson, for more than a decade. He was a founding partner responsible for establishing McKinsey's presence in Silicon Valley and a leader of McKinsey's Business Technology office globally. Owen was also chief executive officer of MindCrossing. Owen currently sits on the boards of Nadro, S.A. de C.V, Proventys, and MedVantx. Owen, who was born and raised in Wales, holds a law degree from Oxford University and an MBA from Stanford University.
Mark Walchirk is responsible for provider sales and services to oncology, rheumatology, urology, nephrology and other specialty practices. Walchirk is also responsible for McKesson Specialty Health’s distribution operations including manufacturer supply chain services. Prior to his current role, Walchirk served as president for McKesson Specialty Care Solutions, a division of McKesson Corporation. Previously, Walchirk served as senior vice president (SVP) and chief operating officer of McKesson U.S. Pharmaceutical, and was responsible for McKesson’s pharmaceutical sales, distribution and customer service operations in the U.S., where McKesson is the leading pharmaceutical wholesaler. Walchirk had been in this role since 2006. Walchirk joined McKesson in 2001 as senior vice president, National Accounts. He was named SVP of the southwest region in 2003. Walchirk led the successful integration of McKesson and D&K Healthcare Resources, the St. Louis-based wholesaler McKesson acquired in mid-2005. Before joining McKesson, Walchirk spent 13 years in medical-surgical distribution and manufacturing with Baxter Healthcare, Allegiance Healthcare and Encompass Group, holding various leadership positions in sales, marketing, operations and business development. Walchirk is a 1988 graduate of the University of Illinois holding a BS in business administration. He also serves on the board for the Center for Healthcare Supply Chain Research and GS1 Healthcare US. .
Asif Ahmad joined US Oncology, now a part of McKesson Specialty Health, in 2010 as the executive vice president, Technology Services. He currently manages Information and Technology Services, where he is responsible for leading the development and evolution of strategy related to information technology and the company’s several information technology-based businesses and services.
Roy A. Beveridge, M.D., is Chief Medical Officer for McKesson Specialty Health. He joined US Oncology’s executive team in September of 2009 as executive vice president and medical director, and continued as part of the leadership team of McKesson Specialty Health after McKesson acquired the company in 2010. Prior to joining US Oncology, Dr. Beveridge served as a medical oncologist caring for patients at Fairfax Northern Virginia Hematology Oncology in Northern Virginia within The US Oncology Network.
Grant Bogle joined US Oncology, now McKesson Specialty Health, in June 2007 as senior vice president, regional operations, Northeast region. In the summer of 2009, he was appointed to the executive committee of US Oncology, and later assumed his current role in McKesson Specialty Health overseeing research, marketing, communications and bio-pharmaceutical sales following the merger between McKesson Specialty Care Solutions and US Oncology.
Patrick Broderick is the General Counsel of McKesson Distribution Solutions, managing the legal resources supporting all businesses within McKesson’s $100 billion a year Distribution Solutions segment. Broderick first joined McKesson’s law department in 1993. Before returning to McKesson in 2008, he served as General Counsel and Corporate Secretary of three publicly traded healthcare companies. Patrick received his BA degree, summa cum laude, from Harvard College and his J.D. from Yale Law School, where he served as an editor of the Yale Law Journal.
Chuck Dowling has responsibility for physician services, specifically customers in The US Oncology Network relationship. Previously, he was the senior vice president of regional operations for US Oncology, serving the Texas Oncology physician practices - the largest practice in The US Oncology Network, with over 300 physicians, 40 cancer centers, 120 sites of service and 3000 employees. Dowling joined US Oncology, now McKesson Specialty Health, in July of 1999 and has helped the company grow from a practice management company into a comprehensive oncology solutions organization that touches nearly every aspect of advancing the quality of patient care and the science of cancer care. Dowling’s 35-year career includes experiences on both the product and service side of healthcare. He started his professional career with Baxter Healthcare, where he spent eight of his eleven years with the company as an expatriate, managing quality control and manufacturing operations in the Caribbean, Middle East, Europe and Asia. After Baxter, Dowling’s experiences included sales and marketing manager, Australian Filtration company; a manager of manufacturing operations for Cordis Corporation; a general manager for Caremark in their Home Infusion Therapy business; a regional vice president in Texas for Vitas Hospice, and just prior to US Oncology, a vice president for a home care and medical equipment provider in Dallas, Texas.
Becky Frank joined McKesson in 2003 as part of Corporate Strategy. In this role, she led various initiatives, evaluating new business opportunities and the impact of legislation on the corporate business. She has worked with McKesson Specialty Health in a dedicated capacity since 2006 to support leadership teams in development and execution of strategic business priorities, including the acquisitions of OTN and US Oncology. Prior to McKesson, Frank worked in consulting to evaluate new market entry sales and distribution strategies for large food & beverage companies. Frank received an MBA and MPH from the University of California, Berkeley and an BA in Biological Anthropology from Harvard College. Frank has lived and taught overseas.
Kirk Kaminsky is currently senior vice president, Strategy and Business Development, supporting McKesson Specialty Health. In this role, Kaminsky is responsible developing and driving strategic initiatives across the organization and leading a Houston-based strategy team. Kaminsky also provides strategic guidance and insight as a member of the McKesson Specialty Health executive committee. Kaminsky has been with McKesson since 2003. Most recently, Kaminsky was senior vice president of McKesson’s U.S. Pharmaceutical Packaging Division, with direct P&L ownership and oversight of McKesson’s RxPak and Sky Pharmaceuticals. Kaminsky joined McKesson as a member of the Corporate Strategy and Business Development Group in San Francisco. Prior to McKesson, Kaminsky was with Bank One Corporation where he was responsible for setting and executing payment strategies across the commercial and retail bank. He also worked with Lehman Brothers for several years as an investment banking financial analyst, concentrating on corporate finance for healthcare and consumer retail. Kaminsky received a MBA from The Wharton School and a BA in Economics for Business from Occidental College.
Anne-Marie Law is the senior vice president of Human Resources for McKesson Specialty Health, a division of McKesson Corporation. She joined McKesson Corporation as vice president, Human Resources in April 2009, leading the Corporate Human Resources team based in San Francisco. Law has a successful track record in the United States and Europe in senior human resources roles at Verisign, Xilinix and Intel in the technology sector, as well as Marks and Spencer, a large British retailer. With a strong background in organizational change, employee engagement and talent development, Law has demonstrated the ability to drive business performance. She also has a passion for building and collaborating with teams within HR and across functions. Law is a native of England and received her Diploma in Personnel Management at the National College of Ireland, and BA at Leicester University in the UK.
Jennifer Webster was named vice president and chief financial officer for McKesson Corporation’s specialty pharmaceuticals business unit, now McKesson Specialty Health, in 2007. In this role, she is responsible for managing all aspects of the financial organization, including financial analysis, forecasting, budgeting, long-range financial strategic plans, accounting, GAAP and SEC compliance, internal controls, customer pricing and credit. She also acts as a business partner and driver in growing business earnings organically and through investments. Webster’s experience across the finance spectrum includes financial planning, business analytics, operations finance and mergers and acquisitions. She joined McKesson in 2001 as director of Finance for the U.S. Pharmaceutical organization and was promoted to vice president, Financial Planning and Analysis. In 2005, she moved into the Corporate Finance division in a similar capacity. During her years at McKesson, Webster has distinguished herself as a highly capable leader, skilled at developing strong teams, forging effective relationships and developing highly-effective finance organizations. Prior to joining McKesson, Webster held several different finance positions over eight years at General Electric and was director of Finance for Scient Corporation. Webster holds a bachelor’s degree in Business Administration from the University of Massachusetts-Amherst and completed the Executive Development Program at the Kellogg School of Management.
David W. Young joined US Oncology, now McKesson Specialty Health, in June 2005 as vice president of Finance responsible for the financial function of the Bio-Pharmaceutical Solutions Group. During his more than five years at US Oncology, Young held roles of increasing responsibility, including Interim CFO at the end of 2010 and senior vice president of the Bio-Pharmaceutical Group where he had direct responsibility for the pharmaceutical relationships and businesses of US Oncology. Young was named to the leadership team of McKesson Specialty Health after McKesson acquired US Oncology in late 2010. Young has more than 20 years of financial and operations experience in a variety of industries, including health care, financial services, logistics and transportation. Prior to joining US Oncology in 2005, Young served as a senior manager at Arthur Anderson and as senior vice president of Finance at Coach USA. He is a graduate of the University of Strathclyde in Scotland. |
|
|
|
